Weekly Digest – 08-14 Apr 2023 Weekly Digest – 08-14 Apr 2023 13 Apr 2023: Keytruda (Pembrolizumab) / Gastric or Gastroesophageal Junction Adenocarcinoma (GEJ) / Merck: US FDA accepted new Supplemental Biologics License Application (sBLA) The FDA has accepted a […]
Weekly Digest – 08-14 Apr 2023 Weekly Digest – 08-14 Apr 2023 11 Apr 2023: Senaparib / Ovarian cancer / Shanghai Junshi Biosciences / IMPACT Therapeutics: Phase 3 maintenance study met primary endpoints Shanghai Junshi Biosciences announced that Phase 3 […]
Weekly Digest – 08-14 Apr 2023 Weekly Digest – 08-14 Apr 2023 11 Apr 2023: Toripalimab / NSCLC / Junshi Biosciences: Accepted Supplemental New Drug Application in China The NMPA had formally accepted the NDA submitted by Junshi Biosciences for […]
Weekly Digest – 08-14 Apr 2023 Weekly Digest – 08-14 Apr 2023 10 Apr 2023: TP-1287 / Ewing Sarcoma / Sumitomo Pharma: US FDA granted Orphan Drug Designation FDA granted Orphan Drug Designation to TP-1287 for the treatment of patients […]
